📰
Sourced From
CNBC
Read Full Article →

Overblown fears surrounding GLP-1 weight loss drugs were already pressuring the stock when an onboarding stumble triggered a sell-off.

Source: CNBCRead full article →


Content sourced from third parties. Copyright belongs to original publishers.


Leave a Reply

Your email address will not be published. Required fields are marked *